Valeant: A Good Start? | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/10/valeant-a-good-start/

Valeant Pharmaceuticals International’s (VRX) debt load is so big that it made an asset sale nearly unavoidable. Sure, the Salix sale fell through–not received well by the market–but Valeant had other assets, and now they’ve announced that they’re selling a bunch of them: Dendreon, which makes cancer treatments, … http://internationalnewslive.com/valeant-a-good-start/